β-Cell Lipases and Insulin Secretion
- 1Department of Experimental Medical Science, Lund University, Lund, Sweden
- 2Department of Clinical Sciences, Lund University, Lund, Sweden
- Address correspondence and reprint requests to Hindrik Mulder, MD, PhD, Department of Experimental Medical Science, Division of Diabetes, Metabolism, and Endocrinology, Unit of Molecular Metabolism, BMC B11, SE-221 84, Lund, Sweden. E-mail: hindrik.mulder{at}med.lu.se
Abstract
Lipids have been implicated in β-cell stimulus-secretion coupling. Thus, lipases in β-cells would be required to generate coupling factors from intracellular lipids. Indeed, we found that glucose stimulates lipolysis in rodent islets and clonal β-cells. Lipolysis and diglyceride lipase activity in islets are abolished by orlistat, a pan-lipase inhibitor. Moreover, orlistat dose-dependently inhibits glucose- and forskolin-stimulated insulin secretion, while leaving glucose oxidation and the rise in ATP-to-ADP ratio intact. In an effort to identify β-cell lipase(s), we found that hormone-sensitive lipase (HSL), the rate-limiting enzyme for acylglyceride hydrolysis in adipocytes, is active in rodent β-cells. To further address the role of HSL, a global and β-cell–specific inactivation, respectively, of the lipase has been created in mice. Whereas our line of HSL null mice is moderately glucose intolerant due to reduced peripheral insulin sensitivity, it exhibits normal islet metabolism and insulin secretion. Preliminary analysis of the β-cell–specific HSL knockout has revealed no evidence for disturbed islet function. Thus, studies of ours and others indicate that there is a complex lipid regulatory component in β-cell stimulus-secretion coupling. The role of HSL and other lipases needs to be further clarified to provide a balanced view of the role of lipids and lipolysis in β-cells.
- ATGL, adipocyte triglyceride lipase
- FFA, free fatty acid
- GSIS, glucose-stimulated insulin secretion
- HSL, hormone-sensitive lipase
- KATP channel, ATP-sensitive K+ channel
Footnotes
-
This article is based on a presentation at a symposium. The symposium and the publication of this article were made possible by an unrestricted educational grant from Servier.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted May 16, 2006.
- Received March 23, 2006.
- DIABETES











